Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet
- Conditions
- Intubation,Endotracheal
- Interventions
- Drug: Normal saline
- Registration Number
- NCT00912990
- Lead Sponsor
- Rady Children's Hospital, San Diego
- Brief Summary
The investigators' primary specific aims are to demonstrate that:
1. Pediatric patients with normal airways, undergoing elective surgical procedures, can be successfully intubated when deeply sedated, without the use of muscle relaxants using the Shikani Optical Stylet.
2. Shikani intubation of pediatric patients is equally effective in children that are deeply sedated or paralyzed as evidenced by a non-significant difference in:
* Time to intubation (defined as no more than a 30 second time difference between the two groups);
* Incidence of adverse events.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 34
- 6 months of age to 17 years of age (not yet 18)
- Male or female
- English or Spanish speaking
- Normal airway (Mallampati Classification )
- American Society of Anesthesiology Physical Status Classification I or II
- Elective surgical procedure expected to last at least 45 minutes in length
- Written informed consent/assent for participation given by the parent legal guardian and subject (if applicable)
-
< 6 months of age, > 17 years of age
-
Difficult airway (Mallampati Classification)
-
History of previous difficult intubation, suspected abnormal airway: *micrognathia
- facial trauma
- airway tumor
- epiglottitis
- retropharyngeal abscess
- foreign body, etc.
- Scheduled for non-elective, emergent OR procedure
- Parent, legal guardian, or subject is unavailable or unwilling to consent for study participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Normal saline Normal saline Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg Cisatracurium Cisatracurium Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.
- Primary Outcome Measures
Name Time Method Time to Intubation Confirmed by the visualization of three carbon dioxide waveforms. Time to intubation was defined as the time (seconds) required to verify three breaths on an end-tidal carbon dioxide monitor.
- Secondary Outcome Measures
Name Time Method The Number of Adverse Events Recorded from the start of the intubation procedure to the time of successful endotracheal intubation The number of occurrences of each event. One subject may have multiple adverse events.
Trial Locations
- Locations (1)
Rady Children's Hospital
🇺🇸San Diego, California, United States